Association between ALK tyrosine kinase inhibitor and the risk of interstitial lung disease and pneumonitis in non-small cell lung cancer patients: a systematic review
BMC Cancer. 2026 Jan 24.
doi: 10.1186/s12885-026-15612-3.
Online ahead of print.
1 Department of Pharmacy, Guizhou Branch of Shanghai Children's Medical Center Shanghai Jiaotong University School of Medicine, Guiyang, Guizhou, China.
2 Department of Pharmacy, Guizhou Provincial People's Hospital, No.83 Zhongshandong Road, Guiyang, Guizhou Province, China.
3 Office of Health Insurance Administration, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
4 Department of Oncology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
5 Department of Laboratory Medicine, Experimental Cancer Medicine, Karolinska Institute, Stockholm, Sweden.
6 Department of Pharmacy, Guizhou Provincial People's Hospital, No.83 Zhongshandong Road, Guiyang, Guizhou Province, China. zjx19870619@126.com.